Medical Weight Loss

Tirzepatide Injection

Dual-action GIP/GLP-1 for enhanced weight loss

From $250/mo

Pricing varies by protocol

A dual GIP/GLP-1 receptor agonist delivered as a once-weekly injection. Tirzepatide targets two incretin pathways simultaneously for enhanced appetite regulation and metabolic improvement. This dual mechanism may produce greater appetite suppression and metabolic benefits compared to single-pathway agents. Prescribed and monitored by your clinician with individualized dose titration.

Get Started See All Weight Loss Treatments

Licensed Providers · Lab-Guided · Ongoing Support

Key Benefits

Dual Receptor Targeting — Activates both GIP and GLP-1 pathways for a more comprehensive metabolic response.
Enhanced Weight Loss — Clinical data suggests greater appetite suppression and weight reduction vs. single-pathway agents.
Once-Weekly Injection — Simple subcutaneous injection, one time per week — minimal disruption to your routine.
Metabolic Improvement — Supports blood sugar regulation, insulin sensitivity, and cardiovascular markers.

How It Works

Your provider reviews your labs and health history, then prescribes a personalized protocol. Medication is shipped directly to your door from a licensed 503A pharmacy. Your provider monitors your progress with regular lab work and adjusts your plan as needed.

What to Expect

Most patients begin noticing improvements within the first few weeks of treatment. Your provider will schedule follow-up labs and check-ins to track your progress and optimize your protocol over time.

Tirzepatide Injection

Who It's For

Other Weight Loss Options

Tirzepatide Oral Tablet

Tirzepatide Sublingual

Semaglutide Injection

Semaglutide Oral Tablet

Semaglutide Sublingual

Ready to Start Your Weight Loss Journey?